The U.S. fluoroscopy systems market size was estimated at USD 163.3 million in 2025 and is projected to reach USD 217.5 million by 2033, growing at a CAGR of 4.2% from 2026 to 2033. This robust growth is driven by the increasing demand for real-time and accurate imaging in diagnostic and interventional procedures.
Healthcare providers are focusing more on precision-based treatments, especially in areas such as cardiology, orthopedics, and gastroenterology, where fluoroscopy plays a critical role. The growing preference for minimally invasive procedures is further boosting the adoption of fluoroscopy systems, as these technologies enable better visualization and improved patient outcomes with shorter recovery times. The rising prevalence of kidney and urinary tract diseases plays critical role in the growth of U.S. fluoroscopy systems market. Fluoroscopy provides real-time visualization during minimally invasive procedures, allowing physicians to guide catheters, stents, and other instruments with precision. As chronic kidney disease and urinary disorders continue to affect a significant portion of the U.S. population, healthcare facilities increasingly depend on fluoroscopy systems to support safe and efficient interventions. According to the Centers for Disease Control and Prevention (CDC) report “Chronic Kidney Disease in the United States, 2023,” published in May 2024, more than 1 in 7 U.S. adults (about 35.5 million people) are estimated to have chronic kidney disease, highlighting a significant and growing healthcare burden. The CDC also notes that many individuals remain undiagnosed, increasing the need for early detection and image-guided clinical interventions. This rising disease prevalence supports growing demand for advanced diagnostic and treatment technologies, including fluoroscopy systems used in minimally invasive kidney and urinary tract procedures.
In urology specifically, fluoroscopy is widely used in minimally invasive procedures for kidney stones, urinary obstructions, and related disorders. Kidney stones are a common condition requiring imaging guidance for treatment planning and intervention, and NIDDK notes that about 11% of men and 6% of women in the U.S. experience kidney stones at least once during their lifetime. Fluoroscopy helps urologists visualize the urinary tract in real time during procedures such as ureteroscopy and stent placement, enabling precise instrument navigation while reducing procedural complexity. As the incidence of these conditions rises, the use of fluoroscopy in routine urology practice continues to expand.
Another important factor is that urologic diseases increasingly require efficient, minimally invasive treatment approaches where fluoroscopy plays a central role. Clinical guidance from professional urology organizations emphasizes optimized fluoroscopy use during surgery to improve outcomes while managing radiation exposure, reflecting how essential fluoroscopic guidance has become in modern urologic workflows. Real-time imaging allows physicians to reduce surgical trauma and procedure time, which is particularly valuable for complex kidney and urinary tract interventions. This growing procedural reliance directly supports demand for advanced fluoroscopy systems tailored for urology settings.
Recent population estimates also show a continuing rise in the older age group, reinforcing long-term demand for imaging systems that support efficient and precise treatment workflows. According to a Pew Research Center report published in January 2024, the U.S. centenarian population (people aged 100 and older) is projected to grow from about 101,000 in 2024 to nearly 422,000 by 2054, highlighting a significant long-term demographic shift toward an older population. This trend reflects broader aging dynamics in the U.S., where the number of adults aged 65 and above is also expected to rise substantially over the coming decades. This growing elderly population increases demand for healthcare services, including minimally invasive and image-guided procedures supported by technologies such as fluoroscopy.
This product will be delivered within 1-3 business days.
Healthcare providers are focusing more on precision-based treatments, especially in areas such as cardiology, orthopedics, and gastroenterology, where fluoroscopy plays a critical role. The growing preference for minimally invasive procedures is further boosting the adoption of fluoroscopy systems, as these technologies enable better visualization and improved patient outcomes with shorter recovery times. The rising prevalence of kidney and urinary tract diseases plays critical role in the growth of U.S. fluoroscopy systems market. Fluoroscopy provides real-time visualization during minimally invasive procedures, allowing physicians to guide catheters, stents, and other instruments with precision. As chronic kidney disease and urinary disorders continue to affect a significant portion of the U.S. population, healthcare facilities increasingly depend on fluoroscopy systems to support safe and efficient interventions. According to the Centers for Disease Control and Prevention (CDC) report “Chronic Kidney Disease in the United States, 2023,” published in May 2024, more than 1 in 7 U.S. adults (about 35.5 million people) are estimated to have chronic kidney disease, highlighting a significant and growing healthcare burden. The CDC also notes that many individuals remain undiagnosed, increasing the need for early detection and image-guided clinical interventions. This rising disease prevalence supports growing demand for advanced diagnostic and treatment technologies, including fluoroscopy systems used in minimally invasive kidney and urinary tract procedures.
In urology specifically, fluoroscopy is widely used in minimally invasive procedures for kidney stones, urinary obstructions, and related disorders. Kidney stones are a common condition requiring imaging guidance for treatment planning and intervention, and NIDDK notes that about 11% of men and 6% of women in the U.S. experience kidney stones at least once during their lifetime. Fluoroscopy helps urologists visualize the urinary tract in real time during procedures such as ureteroscopy and stent placement, enabling precise instrument navigation while reducing procedural complexity. As the incidence of these conditions rises, the use of fluoroscopy in routine urology practice continues to expand.
Another important factor is that urologic diseases increasingly require efficient, minimally invasive treatment approaches where fluoroscopy plays a central role. Clinical guidance from professional urology organizations emphasizes optimized fluoroscopy use during surgery to improve outcomes while managing radiation exposure, reflecting how essential fluoroscopic guidance has become in modern urologic workflows. Real-time imaging allows physicians to reduce surgical trauma and procedure time, which is particularly valuable for complex kidney and urinary tract interventions. This growing procedural reliance directly supports demand for advanced fluoroscopy systems tailored for urology settings.
Recent population estimates also show a continuing rise in the older age group, reinforcing long-term demand for imaging systems that support efficient and precise treatment workflows. According to a Pew Research Center report published in January 2024, the U.S. centenarian population (people aged 100 and older) is projected to grow from about 101,000 in 2024 to nearly 422,000 by 2054, highlighting a significant long-term demographic shift toward an older population. This trend reflects broader aging dynamics in the U.S., where the number of adults aged 65 and above is also expected to rise substantially over the coming decades. This growing elderly population increases demand for healthcare services, including minimally invasive and image-guided procedures supported by technologies such as fluoroscopy.
U.S. Fluoroscopy Systems Market Report Segmentation
This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the U.S. fluoroscopy systems market report based on product, application, and end use.Product Outlook (Revenue, USD Million, 2021-2033)
- Dedicated urology fluoroscopy tables
- Fixed multipurpose fluoroscopy for Urology
Application Outlook (Revenue, USD Million, 2021-2033)
- Upper Urinary Tract Imaging & Diagnostics
- Endourology & Stone Management Procedures
- Lower Urinary Tract Studies
- Interventional Urology
- Post-operative/Follow-up Fluoroscopic Assessments
End Use Outlook (Revenue, USD Million, 2021-2033)
- Hospitals
- Not-for-Profit
- For Profit
- Specialty Centers
- Ambulatory/Outpatient Centers
- Others
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. U.S. Fluoroscopy Systems Market: Methodology and Scope
Chapter 2. U.S. Fluoroscopy Systems Market: Executive Summary
Chapter 3. U.S. Fluoroscopy Systems Market: Variables, Trends, & Scope
Chapter 4. U.S. Fluoroscopy Systems Market: Product Estimates & Trend Analysis
Chapter 5. U.S. Fluoroscopy Systems Market: Application Estimates & Trend Analysis
Chapter 6. U.S. Fluoroscopy Systems Market: End Use Estimates & Trend Analysis
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- GE HealthCare
- Siemens Healthcare GmbH
- Koninklijke Philips N.V.
- Canon Medical Systems
- Shimadzu Corporation
- Dornier MedTech
- UMG / DEL MEDICAL
